BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Tresiba (insulin degludec) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Tresiba (insulin degludec)\, from Clinica
 lTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07173712-318@assetmemo.bio
DTSTAMP:20261121T004948Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:Tresiba (insulin degludec): Phase 4 readout est. (NCT07173712)
DESCRIPTION:Tresiba (insulin degludec)\, phase 4\, Type 2 Diabetes.\nStudy:
  Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 D
 iabetes\nEstimated primary completion: 30 June 2027. This is a ClinicalTri
 als.gov estimate\, not a confirmed readout date\, and it can move.\nDrug p
 age: https://assetmemo.bio/drug/insulin-degludec#upcoming-events\nRegistry
  record: https://clinicaltrials.gov/study/NCT07173712
URL:https://assetmemo.bio/drug/insulin-degludec#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
